vs
STANDARD BIOTOOLS INC.(LAB)与TIMBERLAND BANCORP INC(TSBK)财务数据对比。点击上方公司名可切换其他公司
TIMBERLAND BANCORP INC的季度营收约是STANDARD BIOTOOLS INC.的1.1倍($21.7M vs $19.6M),TIMBERLAND BANCORP INC净利率更高(37.8% vs -177.4%,领先215.2%),TIMBERLAND BANCORP INC同比增速更快(10.4% vs -11.5%),TIMBERLAND BANCORP INC自由现金流更多($5.6M vs $-23.1M),过去两年TIMBERLAND BANCORP INC的营收复合增速更高(9.1% vs -12.2%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
Timberland Bancorp Inc是总部位于美国华盛顿州的银行控股公司,提供个人及商业银行全品类服务,涵盖储蓄与支票账户、住房及商业抵押贷款、小微企业贷款、财富管理解决方案,服务区域内个人及中小商业客户。
LAB vs TSBK — 直观对比
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $21.7M |
| 净利润 | $-34.7M | $8.2M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | 37.8% |
| 营收同比 | -11.5% | 10.4% |
| 净利润同比 | -28.8% | 19.8% |
| 每股收益(稀释后) | $-0.09 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | — | $21.7M | ||
| Q3 25 | $19.6M | $22.5M | ||
| Q2 25 | $21.8M | $20.5M | ||
| Q1 25 | $40.8M | $19.9M | ||
| Q4 24 | — | $19.7M | ||
| Q3 24 | $22.1M | $19.5M | ||
| Q2 24 | $22.5M | $18.8M | ||
| Q1 24 | $45.5M | $18.3M |
| Q4 25 | — | $8.2M | ||
| Q3 25 | $-34.7M | $8.4M | ||
| Q2 25 | $-33.5M | $7.1M | ||
| Q1 25 | $-26.0M | $6.8M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | $-26.9M | $6.4M | ||
| Q2 24 | $-45.7M | $5.9M | ||
| Q1 24 | $-32.2M | $5.7M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | -168.5% | — | ||
| Q2 25 | -118.1% | — | ||
| Q1 25 | -80.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -120.9% | — | ||
| Q2 24 | -134.5% | — | ||
| Q1 24 | -132.2% | — |
| Q4 25 | — | 37.8% | ||
| Q3 25 | -177.4% | 37.6% | ||
| Q2 25 | -153.7% | 34.6% | ||
| Q1 25 | -63.8% | 33.9% | ||
| Q4 24 | — | 34.9% | ||
| Q3 24 | -122.0% | 32.6% | ||
| Q2 24 | -203.3% | 31.6% | ||
| Q1 24 | -70.6% | 31.3% |
| Q4 25 | — | $1.04 | ||
| Q3 25 | $-0.09 | $1.06 | ||
| Q2 25 | $-0.09 | $0.90 | ||
| Q1 25 | $-0.07 | $0.85 | ||
| Q4 24 | — | $0.86 | ||
| Q3 24 | $-0.07 | $0.80 | ||
| Q2 24 | $-0.12 | $0.74 | ||
| Q1 24 | $-0.27 | $0.70 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $246.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $268.4M |
| 总资产 | $539.6M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
| Q4 25 | — | $246.9M | ||
| Q3 25 | $129.4M | $243.4M | ||
| Q2 25 | $158.6M | $193.6M | ||
| Q1 25 | $150.9M | $191.2M | ||
| Q4 24 | — | $164.1M | ||
| Q3 24 | $210.6M | $164.7M | ||
| Q2 24 | $269.8M | $158.9M | ||
| Q1 24 | $287.1M | $180.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $268.4M | ||
| Q3 25 | $399.7M | $262.6M | ||
| Q2 25 | $424.5M | $256.7M | ||
| Q1 25 | $454.6M | $252.5M | ||
| Q4 24 | — | $249.2M | ||
| Q3 24 | $489.3M | $245.4M | ||
| Q2 24 | $510.3M | $241.2M | ||
| Q1 24 | $577.3M | $238.7M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $539.6M | $2.0B | ||
| Q2 25 | $557.0M | $2.0B | ||
| Q1 25 | $579.6M | $1.9B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | $681.5M | $1.9B | ||
| Q2 24 | $708.7M | $1.9B | ||
| Q1 24 | $777.7M | $1.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $6.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $5.6M |
| 自由现金流率自由现金流/营收 | -118.1% | 25.7% |
| 资本支出强度资本支出/营收 | 4.5% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 0.74× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $56.5M |
8季度趋势,按日历期对齐
| Q4 25 | — | $6.1M | ||
| Q3 25 | $-22.2M | $30.2M | ||
| Q2 25 | $-20.7M | $10.8M | ||
| Q1 25 | $-30.3M | $12.4M | ||
| Q4 24 | — | $-3.1M | ||
| Q3 24 | $-27.9M | $23.0M | ||
| Q2 24 | $-39.0M | $7.4M | ||
| Q1 24 | $-62.5M | $4.1M |
| Q4 25 | — | $5.6M | ||
| Q3 25 | $-23.1M | $28.4M | ||
| Q2 25 | $-22.6M | $10.3M | ||
| Q1 25 | $-35.3M | $12.2M | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | $-30.1M | $21.7M | ||
| Q2 24 | $-41.0M | $7.2M | ||
| Q1 24 | $-63.3M | $3.6M |
| Q4 25 | — | 25.7% | ||
| Q3 25 | -118.1% | 126.4% | ||
| Q2 25 | -103.6% | 50.5% | ||
| Q1 25 | -86.6% | 61.1% | ||
| Q4 24 | — | -18.1% | ||
| Q3 24 | -136.4% | 111.5% | ||
| Q2 24 | -182.2% | 38.4% | ||
| Q1 24 | -138.9% | 19.8% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | 4.5% | 7.7% | ||
| Q2 25 | 8.7% | 2.1% | ||
| Q1 25 | 12.4% | 1.0% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 10.2% | 6.7% | ||
| Q2 24 | 8.6% | 1.1% | ||
| Q1 24 | 1.7% | 2.7% |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 3.57× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | -0.45× | ||
| Q3 24 | — | 3.62× | ||
| Q2 24 | — | 1.25× | ||
| Q1 24 | — | 0.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
TSBK
暂无分部数据